Pediatric low-grade glioma (pLGG) is the most common form of pediatric brain cancer. Day One’s OJEMDA™ is the first targeted treatment for pLGG tumors with BRAF fusions and mutations. Last week, on April 23, 2024, Day One Biopharmaceuticals was granted Accelerated […]
Funds to support cutting-edge immunotherapy trial for pediatric high-grade glioma Bethesda, MD – February 8, 2020 – CureSearch for Children’s Cancer has received a $1 million gift from the Norcross Family Foundation in support of a first-in-human, phase I/II clinical trial testing
CureSearch for Children’s Cancer receives gift to support promising immunotherapy trial Read More »
Industry leaders collaborate to accelerate the pace of pediatric drug development Bethesda, Md. – November 3, 2021– CureSearch for Children’s Cancer announced today the addition of five new members to its Industry Advisory Council (IAC), as well as the appointment of Jeffrey
Global leaders in oncology, biotech join CureSearch Industry Advisory Council Read More »
FOR IMMEDIATE RELEASE Media Contact: Margetta Thomas, Communications Manager margetta.thomas@curesearch.org Novel immunotherapy approach could improve survival rate for acute myeloid leukemia Bethesda, Md. – September 15, 2021 – CureSearch for Children’s Cancer, in partnership with the SebastianStrong Foundation, has awarded a three-year, $270,650 CureSearch Young Investigator grant
FOR IMMEDIATE RELEASE Media Contact: Margetta Thomas, Communications Manager margetta.thomas@curesearch.org Collaborative forum to address the unique aspects and challenges of pediatric cancer clinical trial design Bethesda, MD – September 9, 2021 – CureSearch for Children’s Cancer will host the virtual 2021 Pediatric Early Development Symposium (PEDS) – Pediatric
Leaders in pediatric oncology converge to improve the next decade of clinical trials Read More »
FOR IMMEDIATE RELEASEMedia Contact: Margetta ThomasCommunications Managermargetta.thomas@curesearch.org Thought leaders work to accelerate the pace of pediatric drug development Bethesda, Md. – August 18, 2021– CureSearch for Children’s Cancer announced today three new members of its Scientific Advisory Council (SAC). The SAC includes best-in-class
Leading pediatric oncologists join CureSearch Scientific Advisory Council Read More »
FOR IMMEDIATE RELEASE Contact: Tiffani Copeland, SVP, Development & Communications tiffani.copeland@curesearch.org Bethesda, Md. – August 16, 2021 – CureSearch for Children’s Cancer is pleased to announce the appointment of Suzanne Finnegan and Ma Cherry Trivedi to its Board of Directors, effective immediately. CureSearch is a national non-profit with
“We were fortunate that CureSearch had just launched their Catapult Award program….It enabled researchers to access up to $2.5M in funding over three years, through a streamlined application process, rather than contending with multiple applications for smaller grants which would have lengthened
Dr. Brenda Weigel named Chair of CureSearch Scientific Advisory Council Bethesda, MD – August 26, 2020 – CureSearch for Children’s Cancer announces that Brenda Weigel, MD, has been appointed as the new chair of the CureSearch Scientific Advisory Council. The Council is comprised of best-in-class
Dr. Brenda Weigel named Chair of CureSearch Scientific Advisory Council Read More »
